European Commission logo
English English
CORDIS - EU research results
CORDIS

ULtrafine particles from TRansportation – Health Assessment of Sources

Project description

Health impact of exposure to nanoparticles from transport

They may be tiny but ultrafine particles (UFPs) can pose a big health risk. For instance, inhalation of these nano-sized particles has been associated with respiratory diseases. Non-regulated nanoparticle emissions from transport sources belong to this category of high concern. The EU-funded ULTRHAS project will reveal the health threats posed by nanoparticles from different transport sources. Specifically, it will address the impact of different transport modes, fuel technologies and wear components, including atmospheric ageing processes, on the physicochemical characteristics of particulate and gaseous emissions. To study the harmful effects in the lung, the project will apply emission measurement, exposure, and toxicity-testing approaches under highly controlled laboratory conditions.

Objective

Current legislative control of particulate matter (PM) based on ambient mass concentrations does not encompass source dependent variation in PM toxicity or the impact of high numbers of nanoparticles (ultrafine particles; UFPs) which contribute little to PM mass. UFPs may pose high risks due to their small size and high number/surface area concentrations and higher propensity to penetrate tissue barriers and reach the circulation and secondary target organs. Non-regulated nanoparticle emissions from transport sources belong to this category of high concern, and the effects of some specific emissions (e.g. particles from wear components or natural gas and jet engines) are either not sufficiently understood or remain undetected by current air quality or certification procedures.

ULTRHAS will specifically address (i) the impact of different transport modes, fuel technologies and wear components, including atmospheric ageing processes, on the physicochemical characteristics of particulate and gaseous emissions; and how these processes and characteristics affects (ii) the biological responses leading to harmful effects in the lung and beyond by applying state-of-the-art emission measurement, exposure and toxicity-testing approaches under highly controlled laboratory conditions. ULTRHAS will (iii) rank the health hazards of different transport mode emissions and (iv) apply an advanced health impact assessment framework incorporating burden of disease methods to quantify baseline and policy scenario impacts for development and prioritization of mitigation measures; and (v) evaluate the future impact and acceptance of new policies on public health, taking into account social aspects.

ULTRHAS will provide enhanced understanding of health threats posed by nanoparticles from different transport modes; optimize a framework for toxicity and hazard assessment of aerosols; provide guidance for prioritization of mitigation measures for future legislation on air pollutants.

Keywords

Call for proposal

H2020-MG-2018-2019-2020

See other projects for this call

Sub call

H2020-MG-2020-TwoStages

Coordinator

FOLKEHELSEINSTITUTTET
Net EU contribution
€ 761 075,00
Address
LOVISENBERGGATA 8
0456 Oslo
Norway

See on map

Region
Norge Oslo og Viken Oslo
Activity type
Research Organisations
Links
Total cost
€ 1 043 905,00

Participants (6)